Viewing nowCeltisseletartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

MFDS item code 201501321 · Approved 2015.03.13 · Insurance code 625500320
Treatment of nephropathy and hypertension in patients with type 2 diabetes and hypertension
This medication is used for the treatment of hypertension and is also effective in preventing and treating kidney disease that may occur in patients with type 2 diabetes. By controlling hypertension, it helps reduce cardiovascular risks and protects kidney function. Therefore, it improves symptoms and complications related to hypertension.
This drug may be taken with or without food, but taking it at the same time each day is recommended. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant use of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this drug is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be used concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Older adults No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age or older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication should not be taken by pregnant women, especially during the second and third trimesters, as it can cause serious harm to the fetus. Patients with severely impaired liver function or certain genetic disorders should also avoid using this medication. Elderly patients, those with kidney problems, patients with very low blood pressure, or low blood volume should use this medication with more caution and follow the physician's instructions. Although this medication lowers blood pressure, side effects such as dizziness, headache, muscle pain, indigestion, and cough may occasionally occur. If symptoms are severe, consult a doctor immediately. As blood potassium levels may rise, it is advisable to avoid taking potassium supplements or medications containing potassium together. Regular blood tests should be performed to monitor potassium levels. Severe hepatitis or kidney failure may occur; therefore, patients with poor liver or kidney function need regular check-ups and must inform their doctor immediately of any abnormalities. There is a risk of hypotension or loss of consciousness while taking this medication; hence, treatment should be sought immediately if symptoms appear. Women who are pregnant or planning to become pregnant should consult a physician, and it is recommended that breastfeeding women discontinue breastfeeding while taking this medication. This medication is not to be administered to children, especially those under 6 years of age or those with severely impaired kidney function. While taking this medication, caution is advised when driving or operating machinery due to possible dizziness or drowsiness. In case of overdose, hypotension and rapid heartbeat may occur, and immediate medical attention should be sought. There may be drug interactions, so it is essential to inform healthcare professionals about any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that prevents air or moisture from entering. It is recommended to store it at room temperature between 1°C and 30°C, away from extremely hot or cold areas.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.